BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

cpi vs gsk2816126

Mechanistic comparison of cpi 1205 and gsk2816126 based on molecular target overlap from BindingDB and ChEMBL binding affinity data.

2
Shared Targets
67%
Jaccard Similarity
83%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.

Evidence Comparison

cpi 1205
Evidence Score
0
PubMed Studies
View full profile →
gsk2816126
Evidence Score
0
PubMed Studies
View full profile →

Target Overlap

cpi and gsk2816126 share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.667 means 67% of the combined target set is bound by both compounds. The IDF-weighted score of 0.827 accounts for non-specific binding to metabolic enzymes.

Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.

Frequently Asked Questions

What do cpi and gsk2816126 have in common?
cpi and gsk2816126 share 2 molecular targets with a Jaccard similarity of 67%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can cpi and gsk2816126 be combined?
cpi and gsk2816126 share 2 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: cpi or gsk2816126?
In the BiohacksAI corpus: cpi has 0 PubMed-indexed studies, gsk2816126 has 0 studies.

Related Comparisons

Similar to cpi

cpi vs tazemetostat2 targetscpi vs s2 targets

Similar to gsk2816126

gsk2816126 vs tazemetostat2 targetsgsk2816126 vs s2 targets
View full cpi profile →View full gsk2816126 profile →Browse all substances →